Nationwide Fund Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,866
Closed -$403K 1489
2017
Q3
$403K Hold
10,866
﹤0.01% 2290
2017
Q2
$403K Buy
10,866
+110
+1% +$3.59K ﹤0.01% 2288
2017
Q1
$302K Sell
10,756
-1,165
-10% -$32.9K ﹤0.01% 2414
2016
Q4
$349K Hold
11,921
﹤0.01% 2355
2016
Q3
$324K Hold
11,921
﹤0.01% 2393
2016
Q2
$222K Buy
11,921
+637
+6% +$13.3K ﹤0.01% 2558
2016
Q1
$305K Sell
11,284
-16,285
-59% -$467K ﹤0.01% 2326
2015
Q4
$831K Sell
27,569
-11,954
-30% -$384K ﹤0.01% 1816
2015
Q3
$1.25M Buy
39,523
+2,660
+7% +$97.1K 0.01% 1612
2015
Q2
$1.44M Buy
36,863
+2,434
+7% +$84K 0.01% 1644
2015
Q1
$1.22M Buy
34,429
+23,318
+210% +$751K ﹤0.01% 1790
2014
Q4
$351K Sell
11,111
-300
-3% -$8.3K ﹤0.01% 2385
2014
Q3
$256K Sell
11,411
-16,397
-59% -$328K ﹤0.01% 2575
2014
Q2
$610K Buy
+27,808
New +$529K ﹤0.01% 2152

Other funds holding PAHC

Nationwide Fund Advisors's PAHC Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Phibro Animal Health (PAHC) in Q4 2017, closing a stake of 10,866 shares — an estimated $403K sold.

Nationwide Fund Advisors first reported a position in PAHC in Q2 2014 and held it in 14 quarters. The position peaked at $1.44M in Q2 2015. 169 funds tracked by Wall St. Rank hold PAHC as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Phibro Animal Health position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 10,866 Phibro Animal Health shares in Q4 2017, an estimated $403K.
  • Nationwide Fund Advisors first reported a position in Phibro Animal Health in Q2 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Phibro Animal Health position peaked at $1.44M in Q2 2015.
  • 169 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.